FDA Inspection 1237528 — Wyeth Pharmaceutical Division of Wyeth Holdings LLC

Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 2410662

The FDA completed an inspection of Wyeth Pharmaceutical Division of Wyeth Holdings LLC on August 28, 2024 in Pearl River, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 28, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pearl River, NY (United States)